Hormonal markers of aging in men with laryngeal carcinoma
✍ Scribed by Paweł Jóźków; Marek Mędraś; Tomasz Kręcicki; Maria Zalesska-Kręcicka
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 180 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Background. Cancer of the larynx, a frequent neoplasm in older people, occurs several times more often in men than in women. Surprisingly, the highest incidence of the disease is observed in the period in which concentrations of a number of hormones (eg, androgens, growth hormone) decrease. Our objective was to look for differences in hormonal markers of aging between men with laryngeal carcinoma and healthy control subjects.
Methods. Seventy-eight men with cancer of the larynx and 51 healthy age-matched controls were recruited for the study. In each of the examined men, serum concentrations of total testosterone, free testosterone, dihydrotestosterone, dehydroepiandrosterone sulfate, steroid-hormone binding globulin, estradiol, and insulin-like growth factor type 1 (IGF-1) were determined.
Results. Men with laryngeal carcinoma had lower serum concentrations of IGF-1 (136 F 75 vs 318 F 141 ng/mL, p < .000001), lower free testosterone (11.95 F 5.38 vs 15.48 F 4.96 pg/mL, p < .001), and lower dihydrotestosterone/total testosterone ratio (0.07 F 0.06 vs 0.09 F 0.04, p < .05) than healthy controls had.
Conclusions. Somatopause seems to be more evident in men with laryngeal carcinoma than in age-matched controls. In our observation, low concentration of IGF-1 predicted the pres-ence of laryngeal carcinoma more than low concentration of free testosterone did.
📜 SIMILAR VOLUMES
## Abstract ## Objectives/Hypothesis: To find biomarkers associated with response to radiotherapy in laryngeal cancer that can be used together with clinical parameters to improve outcome prediction. ## Methods: In this study, 26 patients irradiated for laryngeal carcinomas with a local recurren
## Background: Osteopontin (opn) is a secreted glycoprotein that is detectable in human body fluids. its increased expression has been found in many malignancies, and a stimulatory effect on human prostate carcinoma cells in vitro has been demonstrated. plasma opn levels have been associated with t
The objective of this study was to evaluate tissue and plasma concentrations of arsenic and cobalt in an attempt to discover the role of these elements in the malignant process. Using neutron activation analysis, arsenic and cobalt levels were determined in plasma and in nonmalignant and malignant h